ask="N/A"
ask_size="N/A"
average_daily_volume="54989"
bid="1.8300"
bid_size="2400"
book_value="0.8110"
change="+0.0293"
change_from_200_day_moving_average="0.2137"
change_from_50_day_moving_average="0.3032"
change_from_52_week_high="-1.7406"
change_From_52_week_low="0.7194"
change_in_percent="+1.5339%"
close="1.9394"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-6.98M"
eps_estimate_current_year="-0.1600"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2843000"
high="2.0000"
high_52_weeks="3.6800"
last_trade_date="2/15/2017"
last_trade_price="1.9394"
last_trade_size="1000"
last_trade_time="3:53pm"
low="1.8328"
low_52_weeks="1.2200"
market_capitalization="21.31M"
moving_average_200_day="1.7257"
moving_average_50_day="1.6362"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.0000"
open="1.9200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+12.3840%"
percent_change_from_50_day_moving_average="+18.5322%"
percent_change_from_52_week_high="-47.2989%"
percent_change_from_52_week_low="+58.9672%"
previous_close="1.9101"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3552"
price_per_sales="5.5254"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="CBLI"
volume="58074"
weeks_range_52="1.2200 - 3.6800"
